ORAMORPH SR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oramorph Sr, and what generic alternatives are available?
Oramorph Sr is a drug marketed by Xanodyne Pharms Inc and is included in one NDA.
The generic ingredient in ORAMORPH SR is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oramorph Sr
A generic version of ORAMORPH SR was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for ORAMORPH SR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Clinical Trials: | 3 |
| Patent Applications: | 5,311 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ORAMORPH SR at DailyMed |
Recent Clinical Trials for ORAMORPH SR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Early Phase 1 |
| National Cancer Institute (NCI) | Early Phase 1 |
| Central Hospital, Nancy, France | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ORAMORPH SR
US Patents and Regulatory Information for ORAMORPH SR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-004 | Nov 23, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-003 | Aug 15, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-001 | Aug 15, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
